Combined administration in a single injection of a feline multivalent modified live vaccine against FHV, FCV, and FPLV together with a recombinant FeLV vaccine is both safe and efficacious for all four major feline viral pathogens

Journal of Feline Medicine and Surgery

Volumn 10, Issue 4, 2008, Pages 346-354

  Kanellos, Theo ^a   Sutton, David J ^d   Salisbury, Claire F ^b   Chalmers, William Stuart K ^c  

^a AGRICULTURAL UNIVERSITY OF ATHENS   (Greece)

^b Betty Fold'   (United Kingdom)

^c Intervet UK   (United Kingdom)

^d INTERVET INTERNATIONAL BV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; VACCINE; VIRUS VACCINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; CAT DISEASE; FELINE LEUKEMIA VIRUS; FELINE PANLEUKOPENIA VIRUS; FEMALE; HERPES VIRUS; HERPES VIRUS INFECTION; IMMUNOLOGY; MALE; SAFETY; TREATMENT OUTCOME; VESIVIRUS; VIRUS INFECTION;

ANIMALS; CALICIVIRIDAE INFECTIONS; CALICIVIRUS, FELINE; CAT DISEASES; CATS; FELINE PANLEUKOPENIA; FELINE PANLEUKOPENIA VIRUS; FEMALE; HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS; LEUKEMIA VIRUS, FELINE; LEUKEMIA, FELINE; MALE; SAFETY; TREATMENT OUTCOME; VACCINES, ATTENUATED; VACCINES, COMBINED; VIRAL VACCINES;

CALICIVIRIDAE; FELIDAE; FELINE CALICIVIRUS; FELINE PANLEUKOPENIA VIRUS; HERPESVIRIDAE;

EID: 48449096642     PISSN: 1098612X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfms.2008.02.001     Document Type: Article

References (19)

1. Andre F.E. Development of combined vaccines: manufacturers' viewpoint. Biologicals 22 4 (1994) 317-321
2. Brunner C., Kanellos T., Meli M.L., Sutton D.J., Gisler R., Gomes-Keller M.A., Hofmann-Lehmann R., and Lutz H. Antibody induction after combined application of an adjuvanted recombinant FeLV vaccine and a multivalent live virus vaccine with a chlamydial component. Vaccine 24 (2006) 1838-1846
3. Coutts A.J., Dawson S., Willoughby K., and Gaskell R.M. Isolation of feline respiratory viruses from clinically healthy cats at UK cat shows. Veterinary Record 123 (1994) 555-556
4. Dawson S., Willoughby K., Gaskell R.M., Wood G., and Chalmers W.S. A field trial to assess the effect of vaccination against feline herpesvirus, feline calicivirus and feline panleucopenia virus in 6-week-old kittens. Journal of Feline Medicine and Surgery 3 1 (2001) 17-22
5. Gaskell R., and Willoughby K. Herpesviruses of carnivores. Veterinary Microbiology 69 1-2 (1999) 73-88
6. Gueguen S., Martin V., Bonnet L., Saunier D., Mahl P., and Aubert A. Safety and efficacy of a recombinant FeLV vaccine combined with a live feline rhinotracheitis, calicivirus and panleukopenia vaccine. Veterinary Record 146 13 (2000) 380-381
7. Hoskins J.D. Feline respiratory diseases. Veterinary Clinics of North America Small Animal Practice 29 4 (1999) 945-958
8. Jacobs A.A., Chalmers W.S., Pasman J., van Vugt F., and Cuenen L.H. Feline bordetellosis: challenge and vaccine studies. Veterinary Record 133 (1993) 260-263
9. Johnson R.H., and Povey R.C. Transfer and decline of maternal antibody to feline calicivirus. Canadian Veterinary Journal 24 (1983) 6-9
10. Leutenegger C.M., Boretti F.S., Mislin C.N., Flynn J.N., Schroff M., Habel A., Junghans C., Koenig-Merediz S.A., Sigrist B., Aubert A., Pedersen N.C., Wittig B., and Lutz H. Immunization of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL-12), IL-16, or a CpG motif. Journal of Virology 22 (2000) 10447-10457
11. Mastro J.M., Lewis M.G., Mathes L.E., Sharpee R., Tarr M.J., and Olsen R.G. Feline leukemia vaccine: efficacy, contents and probable mechanism. Veterinary Immunology and Immunopathology 11 3 (1986) 205-213
12. Nambiar P.R., Jackson M.L., Ellis J.A., Chelack B.J., Kidney B.A., and Haines D.M. Immunohistochemical detection of tumor suppressor gene p53 protein in feline injection site-associated sarcomas. Veterinary Pathology 38 2 (2001) 236-238
13. Pastoret P.P., Blancou J., Vannier P., and Verschueren C. Veterinary Vaccinology (1997), Elsevier Science. 0-444-81968-1
14. Poulet H., Brunet S., Boularand C., Guiot A.L., Leroy V., Tartaglia J., Minke J., Audonnet J.C., and Desmettre P. Efficacy of a canarypox virus-vectored vaccine against feline leukaemia. Veterinary Record 153 (2003) 141-145
15. Reed L.J., and Muench H. A simple method of estimating fifty percent endpoints. American Journal of Hygiene 27 (1938) 493-497
16. Roitt I., Brostoff J., and Male D. Immunology (1993), Mosby-Year Book Europe Limited. 0-397-44765-5
17. Sesardic D., Dawes C.S., Mclellan K., Durrani Z., Yost S.E., and Corbel M.J. Non-pertussis components of combination vaccines: problems with potency testing. Biologicals 27 (1999) 177-181
18. Spickler A.R., and Roth J.A. Adjuvants in veterinary vaccines: modes of action and adverse effects. Journal of Veterinary Internal Medicine 17 (2003) 273-281
19. Vascellari M., Melchiotti E., Bozza M.A., and Mutinelli F. Fibrosarcomas at presumed sites of injection in dogs: characteristics and comparison with non-vaccination site fibrosarcomas and feline post-vaccinal fibrosarcomas. Journal of Veterinary Medicine. A, Physiology, Pathology, Clinical Medicine 50 (2003) 286-291